![4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]phenyl]-9-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one in PDB entry 7o27, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/7o27_entity_3_side_image-200x200.png "Hetero dimeric assembly 1 of PDB entry <span class='highlight'>7o27</span> contains 1 copy of <span class='highlight'>4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]phenyl]-9-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one</span>. Side view.")
![4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]phenyl]-9-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one in PDB entry 7o27, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/7o27_entity_3_top_image-200x200.png "Hetero dimeric assembly 1 of PDB entry <span class='highlight'>7o27</span> contains 1 copy of <span class='highlight'>4-[4-[(4,4-dimethylpiperidin-1-yl)methyl]phenyl]-9-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,4,9-triazaspiro[5.5]undecan-2-one</span>. Top view.")
Environment details NEW
UYZ 601 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.